SCHEMBL7185154

SCHEMBL7185154

COc1ccc(OC)c2c([N+](=O)[O-])ccnc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.54
MEN1 O00255 3/20 0.54
LMNA P02545 5/20 0.48
ALDH1A1 P00352 7/20 0.46
TDP1 Q9NUW8 2/20 0.46
L3MBTL1 Q9Y468 3/20 0.43
MAPT P10636 3/20 0.43
KDM4E B2RXH2 2/20 0.43
GAA P10253 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
POLB P06746 2/20 0.42
HPGD P15428 1/20 0.42
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
PDGFRB P09619 1/20 0.40
PDGFRA P16234 1/20 0.40
CTSB P07858 1/20 0.40
PDE10A Q9Y233 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25291696 0.85 KMT2A (0.49) KMT2AMEN1LMNAALDH1A1TDP1
SCHEMBL25247464 0.85 KMT2A (0.49) KMT2AMEN1LMNAALDH1A1TDP1
SCHEMBL25246326 0.82 LMNA (0.51) KMT2AMEN1LMNAALDH1A1TDP1
SCHEMBL25248042 0.82 MEN1 (0.46) KMT2AMEN1LMNAALDH1A1TDP1
SCHEMBL29379649 0.82 KMT2A (0.46) KMT2AMEN1LMNAALDH1A1TDP1
SCHEMBL25259070 0.82 KMT2A (0.46) KMT2AMEN1LMNAALDH1A1TDP1
SCHEMBL25251423 0.81 MEN1 (0.45) KMT2AMEN1LMNAALDH1A1TDP1
SCHEMBL25249147 0.81 LMNA (0.46) KMT2AMEN1LMNAALDH1A1TDP1
SCHEMBL25251704 0.81 KMT2A (0.45) KMT2AMEN1LMNAALDH1A1TDP1
SCHEMBL6537951 0.79 KMT2A (0.51) KMT2AMEN1LMNAALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583150-B1 Cytotoxic propertie; antitumor; pyrido-(3,2-g)quinoline-5,10-diones; benzo(b)pyrido(4,3,2-de)(1,7)-phenanthroline-8-ones LABORATORIE L. LAFON (FR) 2003-06-24 US disclosed
EP-1161432-A1 PHARMACEUTICAL COMPOSITION BASED ON POLYAROMATIC COMPOUNDS LABORATOIRE L. LAFON (FR) 2001-12-12 EP disclosed
WO-2000055160-A1 PHARMACEUTICAL COMPOSITION BASED ON POLYAROMATIC COMPOUNDS LABORATOIRE L. LAFON (FR) 2000-09-21 WO disclosed